School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Kreton Mavromatis MD

  • Department of Medicine
    Professor
  • (404) 321-6111
  • kmavro@emory.edu
Head shot of Kreton Mavromatis

Overview

Dr. Mavromatis is a professor of medicine in the Division of Cardiology at Emory University. He is director of the cardiac catheterization laboratory at the Atlanta VA Medical Center. He also performs Transcatheter Valve and Structural Heart Disease Interventions at Emory University Hospital.

He obtained his MD degree from University of Michigan, completed his Internal Medicine training at the University of Washington, and completed his Cardiology and Interventional Cardiology training at Emory University in 2002.

Dr. Mavromatis also received a Howard Hughes Research Fellowship at the National Institutes of Health and performed a Basic Research fellowship at Emory University. He currently is an associate director of Interventional Cardiology Training Program. He has also been an investigator in a number of important clinical trials, including COURAGE, FREEDOM, FAME II, ISCHEMIA, PARACHUTE and PARTNER, and in several studies of adult stem cells and mental stress in cardiovascular disease.

Academic Appointment

  • Professor of Medicine, Emory University School of Medicine
  • Distinguished Physician, Emory University School of Medicine
  • Associate Professor of Medicine, Department of Medicine, Emory University Department of Medicine
  • Clinical Adjunct Assistant Professor of Medicine, Department of Medicine, Morehouse University School of Medicine

Education

Degrees

  • MD from University of Michigan
  • BS from University of Michigan

Research

Focus

  • My major interest is the pathogenesis and treatment of coronary artery disease. This includes a specific interest in understanding the vascular injury and healing; the treatment of coronary artery disease with medications and percutaneous coronary interevention; and tissue regeneration in ischemic heart disease.

Publications

  • Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial.
    Lancet Volume: 405 Page(s): 1481 - 1490
    04/26/2025 Authors: Fearon WF; Zimmermann FM; Ding VY; Takahashi K; Piroth Z; van Straten AHM; Szekely L; Davidaviius G; Kalinauskas G; Mansour S
  • Invasive vs Conservative Management of Patients With Chronic Total Occlusion: ResultsFrom the ISCHEMIA Trial.
    J Am Coll Cardiol Volume: 85 Page(s): 1335 - 1349
    04/01/2025 Authors: Bangalore S; Mancini GBJ; Leipsic J; Budoff MJ; Xu Y; Anthopolos R; Brilakis ES; Dwivedi A; Spertus JA; Jones PG
  • Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial.
    J Am Coll Cardiol Volume: 85 Page(s): 1317 - 1331
    04/01/2025 Authors: Maron DJ; Newman JD; Anthopolos R; Lu Y; Stevens S; Boden WE; Mavromatis K; Linefsky J; Nair RG; Bockeria O
  • Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial.
    Circ Cardiovasc Qual Outcomes Volume: 18 Page(s): e010849
    03/01/2025 Authors: Slater J; Maron DJ; Jones PG; Bangalore S; Reynolds HR; Fu Z; Stone GW; Kirby R; Hochman JS; Spertus JA
  • Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.
    Circ Cardiovasc Interv Volume: 17 Page(s): e013743
    12/01/2024 Authors: Reynolds HR; Page CB; Shaw LJ; Berman DS; Chaitman BR; Picard MH; Kwong RY; Min JK; Leipsic J; Mancini GBJ
  • Impact of a Chronic Total Occlusion on Outcomes After FFR-Guided PCI or Coronary Bypass Surgery: A FAME 3 Substudy.
    Circ Cardiovasc Interv Volume: 17 Page(s): e014300
    11/01/2024 Authors: Otsuki H; Takahashi K; Zimmermann FM; Mavromatis K; Aminian A; Jagic N; Dambrink J-HE; Kala P; MacCarthy P; Witt N
  • International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial.
    Circ Cardiovasc Qual Outcomes Volume: 17 Page(s): e010534
    10/01/2024 Authors: Ikemura N; Spertus JA; Nguyen D; Fu Z; Jones PG; Reynolds HR; Bangalore S; Bhargava B; Senior R; Elghamaz A
  • Cardiometabolic Co-morbidity Burden and Circulating Biomarkers in Patients With Chronic Coronary Disease in the ISCHEMIA Trials.
    Am J Cardiol Volume: 225 Page(s): 118 - 124
    08/15/2024 Authors: Hamo CE; Liu R; Wu W; Anthopolos R; Bangalore S; Held C; Kullo I; Mavromatis K; McManus B; Newby LK
  • Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
    Circ Cardiovasc Interv Volume: 17 Page(s): e013435
    06/01/2024 Authors: Praco R; Spertus JA; Broderick S; Bangalore S; Rockhold FW; Ruzyllo W; Demchenko E; Nageh T; Grossman GB; Mavromatis K
  • Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials.
    Am Heart J Volume: 266 Page(s): 61 - 73
    12/01/2023 Authors: Newman JD; Anthopolos R; Ruggles KV; Cornwell M; Reynolds HR; Bangalore S; Mavromatis K; Held C; Wallentin L; Kullo IJ
  • Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial.
    Circulation Volume: 148 Page(s): 950 - 958
    09/19/2023 Authors: Zimmermann FM; Ding VY; Pijls NHJ; Piroth Z; van Straten AHM; Szekely L; Davidavicius G; Kalinauskas G; Mansour S; Kharbanda R
  • Impact of Complete Revascularization inthe ISCHEMIA Trial.
    J Am Coll Cardiol Volume: 82 Page(s): 1175 - 1188
    09/19/2023 Authors: Stone GW; Ali ZA; O'Brien SM; Rhodes G; Genereux P; Bangalore S; Mavromatis K; Horst J; Dressler O; Poh KK
  • Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial.
    J Am Coll Cardiol Volume: 82 Page(s): 295 - 313
    07/25/2023 Authors: Mavromatis K; Jones PG; Ali ZA; Stone GW; Rhodes GM; Bangalore S; O'Brien S; Genereux P; Horst J; Dressler O
  • Complete Revascularization in LeftMainDisease: Is it Important?
    JACC Asia Volume: 3 Page(s): 75 - 77
    02/01/2023 Authors: Mavromatis K; Sandesara PB
  • Survival After Invasive or Conservative Management of Stable Coronary Disease.
    Circulation Volume: 147 Page(s): 8 - 19
    01/03/2023 Authors: Hochman JS; Anthopolos R; Reynolds HR; Bangalore S; Xu Y; O'Brien SM; Mavromichalis S; Chang M; Contreras A; Rosenberg Y
  • Association of Residual Ischemic Disease With Clinical Outcomes After Percutaneous Coronary Intervention.
    JACC Cardiovasc Interv Volume: 15 Page(s): 2475 - 2486
    12/26/2022 Authors: Kovach CP; Hebbe A; Glorioso TJ; Barrett C; Barn AE; Mavromatis K; Valle JA; Waldo SW
  • Comparison of Outcomes of Invasive or Conservative Management of Chronic Coronary Disease in Four Randomized Controlled Trials.
    Am J Cardiol Volume: 185 Page(s): 18 - 28
    12/15/2022 Authors: Mavromatis K; Boden WE; Maron DJ; Mancini GBJ; Weintraub WS; Gosselin G; Berman DS; Shaw LJ; Spertus JA; Hochman JS
  • The Trans-Stent FFR Gradient: What Is its Role in Contemporary PCI?
    JACC Cardiovasc Interv Volume: 15 Page(s): 2203 - 2205
    11/14/2022 Authors: Mavromatis K; Sandesara PB
  • The Impact of the ISCHEMIA Trial on Clinical Practice: an Interventionist's Perspective.
    Cardiovasc Drugs Ther Volume: 36 Page(s): 1019 - 1026
    10/01/2022 Authors: Mavromatis K; Gershlick A
  • Radiographic Contrast Media and the Kidney.
    Volume: 17 Page(s): 1234 - 1242
    08/01/2022 Authors: Cashion W; Weisbord SD
  • Multifaceted Intervention to Improve P2Y12 Inhibitor Adherence After Percutaneous Coronary Intervention: A Stepped WedgeTrial.
    J Am Heart Assoc Volume: 11 Page(s): e024342
    07/05/2022 Authors: Ho PM; O'Donnell CI; McCreight M; Bavry AA; Bosworth HB; Girotra S; Grossman PM; Helfrich C; Latif F; Lu D
  • Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKD.
    J Am Heart Assoc Volume: 11 Page(s): e022003
    03/15/2022 Authors: Briguori C; Mathew RO; Huang Z; Mavromatis K; Hickson LJ; Lau WL; Mathew A; Mahajan S; Wheeler DC; Claes KJ
  • Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.
    N Engl J Med Volume: 386 Page(s): 128 - 137
    01/13/2022 Authors: Fearon WF; Zimmermann FM; De Bruyne B; Piroth Z; van Straten AHM; Szekely L; Davidaviius G; Kalinauskas G; Mansour S; Kharbanda R
  • In-Stent Restenosis in Saphenous Vein Grafts (from the DIVA Trial).
    Am J Cardiol Volume: 162 Page(s): 24 - 30
    01/01/2022 Authors: Xenogiannis I; Rangan BV; Uyeda L; Banerjee S; Edson R; Bhatt DL; Goldman S; Holmes DR; Rao SV; Shunk K
  • Functional coronary angiography in symptomatic patients with no obstructive coronary artery disease.
    Volume: 98 Page(s): 827 - 835
    11/01/2021 Authors: Kumar S; Mehta PK; Eshtehardi P; Hung OY; Koh J-S; Kumar A; Al-Badri A; Rabah R; D'Souza M; Gupta S
  • Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies.
    Circulation Volume: 144 Page(s): 728 - 745
    08/31/2021 Authors: Xenogiannis I; Zenati M; Bhatt DL; Rao SV; Rods-Cabau J; Goldman S; Shunk KA; Mavromatis K; Banerjee S; Alaswad K
  • CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial.
    JACC Cardiovasc Imaging Volume: 14 Page(s): 1384 - 1393
    07/01/2021 Authors: Mancini GBJ; Leipsic J; Budoff MJ; Hague CJ; Min JK; Stevens SR; Reynolds HR; O'Brien SM; Shaw LJ; Manjunath CN
  • Adverse clinical outcomes in patients undergoing both PCI and TAVR: Analysis from a pooled multi-center registry.
    Catheter Cardiovasc Interv Volume: 97 Page(s): 529 - 539
    02/15/2021 Authors: Kumar A; Sammour Y; Reginauld S; Sato K; Agrawal N; Lee JM; Meenakshisundaram C; Ramanan T; Kamioka N; Sawant AC
  • Clinical and Quality of Life Outcomes With Chronic Total Occlusion: The ISCHEMIA CTO Substudy
    Volume: 142 Page(s): E477 - E478
    12/15/2020 Authors: Bangalore S; Mancini GB; Leipsic J; Budoff MJ; Xu Y; Anthopolos R; Dwivedi A; Spertus J; Jones P; Mark DB
  • Clinical and Quality of Life Outcomes With Chronic Total Occlusion: The ISCHEMIA CTO Substudy
    Volume: 142 Page(s): E477 - E478
    12/15/2020 Authors: Bangalore S; Mancini GB; Leipsic J; Budoff MJ; Xu Y; Anthopolos R; Dwivedi A; Spertus J; Jones P; Mark DB
  • Coronary Computed Tomography Angiography Compared With Single Photon Emission Computed Tomography Myocardial Perfusion Imaging as a Guide to Optimal Medical Therapy in Patients Presenting With Stable Angina: The RESCUE Trial.
    J Am Heart Assoc Volume: 9 Page(s): e017993
    12/15/2020 Authors: Stillman AE; Gatsonis C; Lima JAC; Liu T; Snyder BS; Cormack J; Malholtra V; Schnall MD; Udelson JE; Hoffmann U
  • Outcomes Following Shock Aortic Valve Replacement: Transcatheter Versus Surgical Approaches.
    Cardiovasc Revasc Med Volume: 21 Page(s): 1313 - 1318
    10/01/2020 Authors: Maidman SD; Lisko JC; Kamioka N; Chen EP; Mavromatis K; Halkos M; Stewart JP; Lattouf OM; Keeling WB; Gleason P
  • Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
    N Engl J Med Volume: 382 Page(s): 1408 - 1419
    04/09/2020 Authors: Spertus JA; Jones PG; Maron DJ; O'Brien SM; Reynolds HR; Rosenberg Y; Stone GW; Harrell FE; Boden WE; Weintraub WS
  • Initial Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med Volume: 382 Page(s): 1395 - 1407
    04/09/2020 Authors: Maron DJ; Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Boden WE; Chaitman BR; Senior R; Lpez-Sendn J; Alexander KP
  • Response by Latif et al to Letter Regarding Article, "Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial".
    Circ Cardiovasc Interv Volume: 13 Page(s): e009174
    04/01/2020 Authors: Latif F; Uyeda L; Edson R; Bhatt DL; Goldman S; Holmes DR; Rao SV; Shunk K; Aggarwal K; Uretsky B
  • Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) study.
    Contemp Clin Trials Volume: 91 Page(s): 105975
    04/01/2020 Authors: Mehta A; Mavromatis K; Ko Y-A; Rogers SC; Dhindsa DS; Goodwin C; Patel R; Martini MA; Prasad M; Mokhtari A
  • A Comparison of Clinical Outcomes According to the Timing of PCI and TAVR: A Pooled Analysis From a Multicenter Registry
    JACC-CARDIOVASCULAR INTERVENTIONS Volume: 13 Page(s): S48 - S49
    02/24/2020 Authors: Kumar A; Sammour Y; Reginauld S; Sato K; Agrawal N; Meenakshisundaram C; Kamioka N; Sawant AC; Devireddy C; Krishnaswamy A
  • Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49).
    Am J Cardiol Volume: 125 Page(s): 485 - 490
    02/15/2020 Authors: Gibson CM; Kumar V; Gopalakrishnan L; Singh P; Guo J; Kazziha S; Devireddy C; Pinto D; Marshall JJ; Stouffer GA
  • Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial.
    Circ Cardiovasc Interv Volume: 13 Page(s): e008494
    02/01/2020 Authors: Latif F; Uyeda L; Edson R; Bhatt DL; Goldman S; Holmes DR; Rao SV; Shunk K; Aggarwal K; Uretsky B
  • What is the Real Message of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) Trial for Academic and Practising Cardiologists?
    Eur Cardiol Volume: 15 Page(s): e64
    02/01/2020 Authors: Mavromatis K; Boden WE
  • Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.
    Circ Cardiovasc Qual Outcomes Volume: 12 Page(s): e005455
    11/01/2019 Authors: Xie JX; Gunzburger EC; Kaun L; Plomondon ME; Barn AE; Waldo SW; Virani SS; Maddox TM; Mavromatis K
  • The role of coronary reactivity testing in women with no obstructive coronary artery disease.
    Curr Opin Cardiol Volume: 34 Page(s): 656 - 662
    11/01/2019 Authors: AlBadri A; Mavromatis K; Bairey Merz CN
  • Direct Stenting Versus Adjunctive Balloon Angioplasty for Saphenous Vein Graft Percutaneous Coronary Intervention
    Volume: 74 Page(s): B662 - B662
    10/01/2019 Authors: Latif F; Uyeda L; Edson R; Holmes D; Rao S; Aggarwal K; Uretsky B; Ziada K; McFalls E; Irimpen A
  • In-Stent Restenosis in Saphenous Vein Grafts: Insights From the DIVA trial
    Volume: 74 Page(s): B661 - B661
    10/01/2019 Authors: Xenogiannis I; Rangan B; Uyeda L; Banerjee S; Edson R; Bhatt D; Holmes D; Rao S; Mavromatis K; Ramanathan K
  • Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert plus contrast reduction system.
    Catheter Cardiovasc Interv Volume: 93 Page(s): 1228 - 1235
    06/01/2019 Authors: Gurm HS; Mavromatis K; Bertolet B; Kereiakes DJ; Amin AP; Shah AP; Hanzel GS; Rao S; Thomas JL; Kumar G
  • IMPACT OF OBESITY ON THE OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Volume: 73 Page(s): 1095 - 1095
    03/12/2019 Authors: Kamioka N; Caughron H; Lisko J; Keegan P; Binongo J; Wei J; Byku I; Alvarez L; Reginauld S; Patel H
  • IMPACT OF HEMODIALYSIS ON EARLY DEGENERATION OF BIOPROSTHESIS AND CLINICAL OUTCOME AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Volume: 73 Page(s): 1096 - 1096
    03/12/2019 Authors: Kamioka N; Caughron H; Lisko J; Binongo J; Almuwaqqat Z; Keegan P; Gleason P; Byku I; Alvarez L; Reginauld S
  • Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.
    JAMA Cardiol Volume: 4 Page(s): 273 - 286
    03/01/2019 Authors: Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Alexander KP; Senior R; Boden WE; Stone GW; Goodman SG; Lopes RD
  • Improving anti-platelet therapy adherence in the Veterans Health Administration: A randomized multi-site hybrid effectiveness-implementation study protocol.
    Contemp Clin Trials Volume: 77 Page(s): 104 - 110
    02/01/2019 Authors: McCreight MS; Lambert-Kerzner A; O'Donnell CI; Grunwald GK; Hebert P; Gillette M; Jneid H; Parashar A; Grossman PM; Helfrich C
  • 1000 Minimalist TAVR: Sapien through Sapien-3
    Volume: 72 Page(s): B107 - B107
    09/25/2018 Authors: Kamioka N; Keegan P; Lerakis S; Binongo J; Caughron H; Reginauld S; Patel H; Maini A; Yousef A; Gleason P
  • Clinical Characteristics and Vascular Complications in Patients Undergoing Transcatheter Aortic Valve Replacement and Percutaneous Coronary Interventions
    Volume: 72 Page(s): B131 - B131
    09/25/2018 Authors: Reginauld S; Kumar A; Kamioka N; Lerakis S; Yousef A; Gleason P; Leshnower B; Devireddy C; Mavromatis K; Stewart J
  • Degenerative mitral regurgitation predicts worse outcomes in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv Volume: 92 Page(s): 574 - 582
    09/01/2018 Authors: Kindya B; Ouzan E; Lerakis S; Gonen E; Babaliaros V; Karayel E; Thourani VH; Gotsman I; Devireddy CM; Danenberg HD
  • Five-Year Outcomes with PCI Guided by Fractional Flow Reserve.
    N Engl J Med Volume: 379 Page(s): 250 - 259
    07/19/2018 Authors: Xaplanteris P; Fournier S; Pijls NHJ; Fearon WF; Barbato E; Tonino PAL; Engstrm T; Kb S; Dambrink J-H; Rioufol G
  • Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial.
    Lancet Volume: 391 Page(s): 1997 - 2007
    05/19/2018 Authors: Brilakis ES; Edson R; Bhatt DL; Goldman S; Holmes DR; Rao SV; Shunk K; Rangan BV; Mavromatis K; Ramanathan K
  • Coronary and Peripheral Vasomotor Responses to Mental Stress.
    J Am Heart Assoc Volume: 7
    05/03/2018 Authors: Hammadah M; Kim JH; Al Mheid I; Samman Tahhan A; Wilmot K; Ramadan R; Alkhoder A; Khayata M; Mekonnen G; Levantsevych O
  • THE EFFECT AND RELATIONSHIP OF AGE AND FRAILTY ON SURVIVAL IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT
    Volume: 71 Page(s): 992 - 992
    03/10/2018 Authors: Kiani S; Stebbins A; Thourani VH; Forcillo J; Vemulapalli S; Kosinski A; Babaliaros V; Cohen D; Kodali SK; Kirtane A
  • Predictors and Clinical Outcomes of Next-Day Discharge After Minimalist Transfemoral Transcatheter Aortic ValveReplacement.
    JACC Cardiovasc Interv Volume: 11 Page(s): 107 - 115
    01/22/2018 Authors: Kamioka N; Wells J; Keegan P; Lerakis S; Binongo J; Corrigan F; Condado J; Patel A; Forcillo J; Ogburn L
  • Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis and Mitral Regurgitation.
    Ann Thorac Surg Volume: 104 Page(s): 1977 - 1985
    12/01/2017 Authors: Mavromatis K; Thourani VH; Stebbins A; Vemulapalli S; Devireddy C; Guyton RA; Matsouaka R; Ghasemzadeh N; Block PC; Leshnower BG
  • A Comparison of the ACURATE Neo and Sapien 3 Valves: Making Progress.
    JACC Cardiovasc Interv Volume: 10 Page(s): 2088 - 2089
    10/23/2017 Authors: Mavromatis K
  • Anatomical risk models for paravalvular leak and landing zone complications for balloon-expandable transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv Volume: 90 Page(s): 690 - 700
    10/01/2017 Authors: Condado JF; Corrigan FE; Lerakis S; Parastatidis I; Stillman AE; Binongo JN; Stewart J; Mavromatis K; Devireddy C; Leshnower B
  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
    N Engl J Med Volume: 377 Page(s): 1119 - 1131
    09/21/2017 Authors: Ridker PM; Everett BM; Thuren T; MacFadyen JG; Chang WH; Ballantyne C; Fonseca F; Nicolau J; Koenig W; Anker SD
  • The Promise of Portico.
    JACC Cardiovasc Interv Volume: 10 Page(s): 1548 - 1549
    08/14/2017 Authors: Mavromatis K
  • Use of troponin assay 99th percentile as the decision level for myocardial infarction diagnosis.
    Am Heart J Volume: 190 Page(s): 135 - 139
    08/01/2017 Authors: Bagai A; Alexander KP; Berger JS; Senior R; Sajeev C; Pracon R; Mavromatis K; Lopez-Sendn JL; Gosselin G; Diaz A
  • SYNTAX scoring: growing stronger.
    Eur Heart J Volume: 38 Page(s): 1978 - 1979
    07/01/2017 Authors: Mavromatis K; King SB
  • End-stage renal disease and severe aortic stenosis: Does valve replacement improve one-year outcomes?
    Catheter Cardiovasc Interv Volume: 89 Page(s): 1109 - 1115
    05/01/2017 Authors: Condado JF; Maini A; Leshnower B; Thourani V; Forcillo J; Devireddy C; Mavromatis K; Sarin EL; Stewart J; Guyton R
  • PREDICTORS AND CLINICAL OUTCOMES OF NEXT-DAY DISCHARGE AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT
    Volume: 69 Page(s): 1944 - 1944
    03/21/2017 Authors: Kamioka N; Wells J; Lerakis S; Corrigan F; Contreras JC; Caughron H; Dong A; Keegan P; Simone A; Binongo J
  • Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents.
    JACC Cardiovasc Interv Volume: 10 Page(s): 462 - 473
    03/13/2017 Authors: El-Hayek G; Bangalore S; Casso Dominguez A; Devireddy C; Jaber W; Kumar G; Mavromatis K; Tamis-Holland J; Samady H
  • Does minimalist transfemoral transcatheter aortic valve replacement produce better survival in patients with severe chronic obstructive pulmonary disease?
    Catheter Cardiovasc Interv Volume: 89 Page(s): 775 - 780
    03/01/2017 Authors: Condado JF; Haider MN; Lerakis S; Keegan P; Caughron H; Thourani VH; Devireddy C; Leshnower B; Mavromatis K; Sarin EL
  • Should We Perform Carotid Doppler Screening Before Surgical or Transcatheter Aortic Valve Replacement?
    Ann Thorac Surg Volume: 103 Page(s): 787 - 794
    03/01/2017 Authors: Condado JF; Jensen HA; Maini A; Ko Y-A; Rajaei MH; Tsai LL; Devireddy C; Leshnower B; Mavromatis K; Sarin EL
  • Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol Volume: 69 Page(s): 367 - 377
    01/31/2017 Authors: Kapadia SR; Kodali S; Makkar R; Mehran R; Lazar RM; Zivadinov R; Dwyer MG; Jilaihawi H; Virmani R; Anwaruddin S
  • Cangrelor With and Without GlycoproteinIIb/IIIa Inhibitors inPatientsUndergoing PercutaneousCoronary Intervention.
    J Am Coll Cardiol Volume: 69 Page(s): 176 - 185
    01/17/2017 Authors: Vaduganathan M; Harrington RA; Stone GW; Deliargyris EN; Steg PG; Gibson CM; Hamm CW; Price MJ; Menozzi A; Prats J
  • Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can risk stratify patients in transcatheter aortic-valve replacement (TAVR).
    Int J Cardiol Volume: 223 Page(s): 444 - 449
    11/15/2016 Authors: Condado JF; Junpaparp P; Binongo JN; Lasanajak Y; Witzke-Sanz CF; Devireddy C; Leshnower B; Mavromatis K; Stewart J; Guyton R
  • TCT-43 Outcomes after paravalvular leak closure: Percutaneous versus Surgical approaches.
    J Am Coll Cardiol Volume: 68 Page(s): B18
    11/01/2016 Authors: Wells J; Condado C J; Kamioka N; Dong A; Ritter A; Lerakis S; Stewart J; Leshnower B; Mavromatis K; Guyton R
  • Rationale and design of the Randomized Evaluation of patients with Stable angina Comparing Utilization of noninvasive Examinations (RESCUE) trial.
    Am Heart J Volume: 179 Page(s): 19 - 28
    09/01/2016 Authors: Stillman AE; Gatsonis C; Lima JAC; Black WC; Cormack J; Gareen I; Hoffmann U; Liu T; Mavromatis K; Schnall MD
  • When Transcatheter Aortic Valve Replacement Is Not Enough: A Step Toward Understanding When ConcomitantMitralRegurgitation Needs Treatment.
    JACC Cardiovasc Interv Volume: 9 Page(s): 1615 - 1617
    08/08/2016 Authors: Mavromatis K
  • Does a Higher Society of Thoracic Surgeons Score Predict Outcomes in Transfemoral and Alternative Access Transcatheter Aortic Valve Replacement?
    Ann Thorac Surg Volume: 102 Page(s): 474 - 482
    08/01/2016 Authors: Jensen HA; Thourani VH; Forcillo J; Condado JF; Binongo JN; Babaliaros V; Lasanajak Y; Leshnower B; Devireddy C; Guyton R
  • Balloon Versus Computed Tomography Sizing of the Aortic Annulus for Transcatheter Aortic Valve Replacement and the Impact of Left Ventricular Outflow Tract Calcification and Morphology on Sizing.
    J Invasive Cardiol Volume: 28 Page(s): 295 - 304
    07/01/2016 Authors: Condado JF; Lerakis S; Stewart J; Jensen H; Henry TS; Ko SM; Stillman A; Rajaei MH; Mavromatis K; Devireddy C
  • Percutaneous Coronary Intervention inNative Coronary Arteries Versus BypassGrafts in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
    JACC Cardiovasc Interv Volume: 9 Page(s): 884 - 893
    05/09/2016 Authors: Brilakis ES; O'Donnell CI; Penny W; Armstrong EJ; Tsai T; Maddox TM; Plomondon ME; Banerjee S; Rao SV; Garcia S
  • "Just Puff": The Continued Quest to Simplify Physiological Lesion Assessment.
    JACC Cardiovasc Interv Volume: 9 Page(s): 768 - 770
    04/25/2016 Authors: Samady H; Mavromatis K
  • TREATMENT OF SEVERE AORTIC STENOSIS IN PATIENTS WITH END-STAGE RENAL DISEASE ON DIALYSIS
    Volume: 67 Page(s): 245 - 245
    04/05/2016 Authors: Contreras JFC; Maini A; Thourani V; Devireddy C; Leshnower B; Mavromatis K; Sarin E; Stewart J; Guyton R; Forcillo J
  • DEGENERATIVE VERSUS FUNCTIONAL MITRAL REGURGITATION IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT FOR SEVERE AORTIC STENOSIS
    Volume: 67 Page(s): 2177 - 2177
    04/05/2016 Authors: Ouzan JM; Kindya B; Gotsman I; Babaliaros V; Gonen E; Leshnower B; Karayel E; Stewart J; Beeri R; Devireddy C
  • MINIMALIST VERSUS STANDARD TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH SEVERE CHRONIC OBSTRUCTIVE LUNG DISEASE
    Volume: 67 Page(s): 416 - 416
    04/05/2016 Authors: Haider M; Contreras JC; Caughron H; Thourani V; Devireddy C; Leshnower B; Mavromatis K; Sarin E; Stewart J; Guyton R
  • Transcatheter Aortic Valve Replacement Results in Improvement of Pulmonary Function in Patients With Severe Aortic Stenosis.
    Ann Thorac Surg Volume: 100 Page(s): 2167 - 2173
    12/01/2015 Authors: Gilmore RC; Thourani VH; Jensen HA; Condado J; Binongo JNG; Sarin EL; Devireddy CM; Leshnower B; Mavromatis K; Syed A
  • Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: Insights from the US TVT National Registry
    Volume: 66 Page(s): B51 - B52
    10/13/2015 Authors: Mavromatis K; Babaliaros V; Stebbins A; Vemulapalli S; Devireddy C; Guyton R; Block PC; Leshnower BG; Sarin E; Stewart J
  • Balloon vs Computed Tomography Sizing of the Aortic Annulus for Transcatheter Aortic Valve Replacement
    Volume: 66 Page(s): B267 - B268
    10/13/2015 Authors: Condado JF; Stewart J; Jensen HA; Lerakis S; Ko SM; Stillman A; Rajaei MH; Mavromatis K; Devireddy C; Sarin E
  • Should we perform carotid artery screening before aortic valve replacement?
    Volume: 66 Page(s): B268 - B268
    10/13/2015 Authors: Condado JF; Jensen HA; Maini A; Ko Y-A; Rajaei MH; Tsai LL; Devireddy C; Leshnower BG; Mavromatis K; Sarin E
  • Minimalist transcatheter aortic valve replacement: The new standard for surgeons and cardiologists using transfemoral access?
    J Thorac Cardiovasc Surg Volume: 150 Page(s): 833 - 839
    10/01/2015 Authors: Jensen HA; Condado JF; Devireddy C; Binongo J; Leshnower BG; Babaliaros V; Sarin EL; Lerakis S; Guyton RA; Stewart JP
  • Outcomes for Transcatheter Aortic Valve Replacement in Nonagenarians.
    Ann Thorac Surg Volume: 100 Page(s): 1261 - 1267
    10/01/2015 Authors: Kayatta MO; Thourani VH; Jensen HA; Condado JC; Sarin EL; Kilgo PD; Devireddy CM; Leshnower BG; Mavromatis K; Li C
  • Transcatheter aortic valve replacement improves functional mitral regurgitation
    Volume: 36 Page(s): 266 - 267
    08/01/2015 Authors: Ouzan E; Kindya B; Ko Y; Block P; Devireddy C; Leshnower B; Babaliaros V; Thourani V; Lerakis S; Mavromatis K
  • SAFETY OF EARLY DISCHARGE AFTER MINIMALIST TRANSCATHETER AORTIC VALVE REPLACEMENT
    Volume: 65 Page(s): A1882 - A1882
    03/17/2015 Authors: Contreras JFC; Jensen HA; Thourani V; Lerakis S; Mavromatis K; Kaebnick B; Binongo J; Hayek S; Syed A; Rahman A
  • EFFECT OF SEVERE LEFT VENTRICULAR DYSFUNCTION ON OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT VERSUS SURGICAL AORTIC VALVE REPLACEMENT: A PROPENSITY SCORE REGRESSION ANALYSIS
    Volume: 65 Page(s): A1998 - A1998
    03/17/2015 Authors: Thourani VH; Gilmore RC; Contreras JC; Jensen HA; Binongo J; Li Q; Sarin E; Devireddy C; Leshnower B; Mavromatis K
  • High-risk patients with inoperative aortic stenosis: use of transapical, transaortic, and transcarotid techniques.
    Ann Thorac Surg Volume: 99 Page(s): 817 - 823
    03/01/2015 Authors: Thourani VH; Li C; Devireddy C; Jensen HA; Kilgo P; Leshnower BG; Mavromatis K; Sarin EL; Nguyen TC; Kanitkar M
  • Revascularization in patients with diabetes: PCI or CABG or none at all.
    Curr Cardiol Rep Volume: 17 Page(s): 565
    03/01/2015 Authors: Mavromatis K; Samady H; King SB
  • Plasma stromal cell-derived factor 1/CXCL12 level predicts long-term adverse cardiovascular outcomes in patients with coronary artery disease.
    Atherosclerosis Volume: 238 Page(s): 113 - 118
    01/01/2015 Authors: Ghasemzadeh N; Hritani AW; De Staercke C; Eapen DJ; Veledar E; Al Kassem H; Khayata M; Zafari AM; Sperling L; Hooper C
  • The imperative of reducing contrast dose in percutaneous coronary intervention.
    JACC Cardiovasc Interv Volume: 7 Page(s): 1294 - 1296
    11/01/2014 Authors: Mavromatis K
  • Circulating progenitor cells are reduced in HIV-positive, anti-retroviral nave patients.
    Int J Cardiol Volume: 176 Page(s): 1150 - 1152
    10/20/2014 Authors: Ghasemzadeh N; Zhang L; Al Mheid I; Li Q; Sperling L; Waller EK; Taylor WR; Guest J; Quyyumi AA; Mavromatis K
  • Transcatheter aortic valve replacement has improved short-term but similar midterm outcomes in isolated aortic valve replacement after prior coronary artery bypass grafting.
    Ann Thorac Surg Volume: 98 Page(s): 1316 - 1324
    10/01/2014 Authors: Nguyen TC; Babaliaros VC; Razavi SA; Kilgo PD; Devireddy CM; Leshnower BG; Mavromatis K; Guyton RA; Kanitkar M; Lerakis S
  • Fractional flow reserve-guided PCI for stable coronary artery disease.
    N Engl J Med Volume: 371 Page(s): 1208 - 1217
    09/25/2014 Authors: De Bruyne B; Fearon WF; Pijls NHJ; Barbato E; Tonino P; Piroth Z; Jagic N; Mobius-Winckler S; Rioufol G; Witt N
  • Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in Patients Presenting with Circulatory Shock Secondary to Inoperable Aortic Stenosis
    Volume: 64 Page(s): B21 - B21
    09/16/2014 Authors: Ibrahim AW; Thourani V; Babaliaros V; Iturra-Urriola S; Mavromatis K; Leshnower BG; Rahman A; Stewart J; Sarin E; Merlino J
  • Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis.
    JACC Cardiovasc Interv Volume: 7 Page(s): 898 - 904
    08/01/2014 Authors: Babaliaros V; Devireddy C; Lerakis S; Leonardi R; Iturra SA; Mavromatis K; Leshnower BG; Guyton RA; Kanitkar M; Keegan P
  • Effect of progenitor cell mobilization with granulocyte-macrophage colony-stimulating factor in patients with peripheral artery disease: a randomized clinical trial.
    JAMA Volume: 310 Page(s): 2631 - 2639
    12/25/2013 Authors: Poole J; Mavromatis K; Binongo JN; Khan A; Li Q; Khayata M; Rocco E; Topel M; Zhang X; Brown C
  • Effect of Progenitor Cell Mobilization with Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Patients with Peripheral Artery Disease and Claudication; GPAD-II: A Phase II Randomized Study
    CIRCULATION Volume: 128 Page(s): 2714 - 2715
    12/17/2013 Authors: Poole J; Mavromatis K; Binongo J; Khan A; Li Q; Khayata M; Rocco E; Neuman R; Morris A; Topel M
  • Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement.
    J Thorac Cardiovasc Surg Volume: 146 Page(s): 1399 - 1406
    12/01/2013 Authors: Nguyen TC; Babaliaros VC; Razavi SA; Kilgo PD; Guyton RA; Devireddy CM; Shults CC; Mavromatis K; Kanitkar M; Block P
  • Stromal Derived Factor-1 Level Predicts Long-Term Adverse Cardiovascular Outcomes in Patients With Stable Coronary Artery Disease
    Volume: 128
    11/26/2013 Authors: Hritani AW; Ghasemzadeh N; Khayata M; Aznaouridis K; Kamineni T; Forghani Z; Reddy PK; De Staercke C; Hooper C; Kumar S
  • Plasma Monocyte Chemoattractant Protein Level Predicts Long-Term Adverse Cardiovascular Outcomes in Patients With Stable Coronary Artery Disease
    Volume: 128
    11/26/2013 Authors: Ghasemzadeh N; Hritani AW; Khayata M; Al Kassem H; Aznaouridis K; Kamineni T; Forghani Z; Reddy PK; De Staercke C; Hooper C
  • Prognostic Value of Angina Related Health Status in Women With Suspected Coronary Artery Disease
    Volume: 128
    11/26/2013 Authors: Khayata M; Ghasemzadeh N; Hritani A; Al Kassem H; Hannah N; Eapen D; Alzaraneh B; Alanbari R; El-Khattabi M; Kaba AN
  • Cost-Effectiveness Of Transcatheter Aortic Valve Replacement By Minimalist Or Standard Approaches
    Volume: 62 Page(s): B235 - B236
    10/29/2013 Authors: Thourani V; Devireddy C; Maas A; Lerakis S; Kilgo P; Leshnower BG; Mavromatis K; Nguyen TC; Kanitkar M; Block PC
  • Use of transaortic, transapical, and transcarotid transcatheter aortic valve replacement in inoperable patients.
    Ann Thorac Surg Volume: 96 Page(s): 1349 - 1357
    10/01/2013 Authors: Thourani VH; Gunter RL; Neravetla S; Block P; Guyton RA; Kilgo P; Lerakis S; Devireddy C; Leshnower B; Mavromatis K
  • A comprehensive acute coronary syndrome algorithm for centers with percutaneous coronary intervention capability.
    Crit Pathw Cardiol Volume: 12 Page(s): 141 - 149
    09/01/2013 Authors: McDaniel M; Ross M; Rab ST; Keadey M; Liberman H; Fantz C; Winkler A; Goyal A; Finn A; Osborne A
  • FAME 2 global ischemic risk score and clinical outcome in patients with stable coronary disease receiving medical therapy alone
    Volume: 34 Page(s): 177 - 177
    08/01/2013 Authors: Toth G; Barbato E; Pijls NHJ; Fearon W; Tonino P; Curzen N; Piroth Z; Wijns W; Mavromatis KA; De Bruyne B
  • HIV-INFECTED TREATMENT-NAIVE INDIVIDUALS HAVE LOW CIRCULATING PROGENITOR CELLS
    Volume: 61 Page(s): E1143 - E1143
    03/12/2013 Authors: Ghasemzadeh N; Zhang L; Li Q; Wirtz SS; Hritani AW; Kumar S; Ofotokun I; Guest JL; Taylor WR; Quyyumi A
  • Same-day discharge after percutaneous coronary intervention: are we ready?
    JACC Cardiovasc Interv Volume: 6 Page(s): 113 - 114
    02/01/2013 Authors: Mavromatis K
  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.
    N Engl J Med Volume: 367 Page(s): 1297 - 1309
    10/04/2012 Authors: Roe MT; Armstrong PW; Fox KAA; White HD; Prabhakaran D; Goodman SG; Cornel JH; Bhatt DL; Clemmensen P; Martinez F
  • Proangiogenic cell colonies grown in vitro from human peripheral blood mononuclear cells.
    J Biomol Screen Volume: 17 Page(s): 1128 - 1135
    10/01/2012 Authors: Mavromatis K; Sutcliffe DJ; Joseph G; Alexander RW; Waller EK; Quyyumi AA; Taylor WR
  • Circulating proangiogenic cell activity is associated with cardiovascular disease risk.
    J Biomol Screen Volume: 17 Page(s): 1163 - 1170
    10/01/2012 Authors: Mavromatis K; Aznaouridis K; Al Mheid I; Veledar E; Dhawan S; Murrow JR; Forghani Z; Sutcliffe DJ; Ghasemzadeh N; Alexander RW
  • Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.
    N Engl J Med Volume: 367 Page(s): 991 - 1001
    09/13/2012 Authors: De Bruyne B; Pijls NHJ; Kalesan B; Barbato E; Tonino PAL; Piroth Z; Jagic N; Mbius-Winkler S; Rioufol G; Witt N
  • Bridging Patients Using Balloon Valvuloplasty in Patients With Acutely Decompensated Heart Failure: A Single Center Experience
    Volume: 18 Page(s): S90 - S90
    08/01/2012 Authors: Patel AD; Stewart J; Clermont E; Mavromatis K; Babaliaros V
  • Transbrachial intra-aortic balloon pumping for high-risk percutaneous coronary intervention.
    Am J Med Sci Volume: 341 Page(s): 153 - 156
    02/01/2011 Authors: Aznaouridis K; Kacharava AG; Consolini M; Zafari AM; Mavromatis K
  • Percutaneous intervention of Cabrol graft-left main anastomosis during acute myocardial infarction.
    Int J Cardiol Volume: 140 Page(s): e27 - e29
    04/15/2010 Authors: Hoskins MH; Kacharava AG; Green TF; Mavromatis K; Veterans Affairs Medical Center, Decatur, GA
  • HIGHER BASELINE INFLAMMATORY BURDEN IS ASSOCIATED WITH WORSE PROGNOSIS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE UNDERGOING CORONARY STENTING
    Volume: 55
    03/09/2010 Authors: Ghasemzadeh N; Forghani Z; Aznaouridis K; Reddy PK; DeStareck C; Hooper C; Quyyumi AA; Mavromatis K
  • Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial.
    Circ Cardiovasc Qual Outcomes Volume: 2 Page(s): 320 - 327
    07/01/2009 Authors: Mancini GBJ; Bates ER; Maron DJ; Hartigan P; Dada M; Gosselin G; Kostuk W; Sedlis SP; Shaw LJ; Berman DS
  • Usefulness of serum high-density lipoprotein cholesterol level as an independent predictor of one-year mortality after percutaneous coronary interventions.
    Am J Cardiol Volume: 103 Page(s): 902 - 906
    04/01/2009 Authors: Ghazzal ZB; Dhawan SS; Sheikh A; Douglas JS; Veledar E; Mavromatis K; Pohlel FK; Vaccarino V
  • Inflammatiory Markers Predict Cardiovascular Outcomes in Patients Undergoing Coronary Drug Eluting Stenting
    Volume: 53 Page(s): A46 - A46
    03/10/2009 Authors: Mavromatis K; Ghasemzadeh N; Aznaouridis K; Forghani Z; Reddy PK; De Staercke C; Hooper WC; Quyyumi AA
  • Circulating Progenitor Cell Levels are Decreased in Patients with Diabetes after Coronary Stenting
    Volume: 102 Page(s): 107I - 107I
    10/12/2008 Authors: Ghasemzadeh N; Forghani Z; Hameed S; Waller EK; Taylor WR; Quyyumi A; Mavromatis K
  • Patients with diabetes have reduced circulating CD34+cells after coronary stenting
    Volume: 28 Page(s): E77 - E77
    06/01/2008 Authors: Mavromatis K; Ghasemzadeh N; Forghani Z; Hameed S; Waller EK; Quyyumi AA; Taylor WR
  • Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.
    JAMA Volume: 299 Page(s): 1561 - 1573
    04/02/2008 Authors: Nissen SE; Nicholls SJ; Wolski K; Nesto R; Kupfer S; Perez A; Jure H; De Larochellire R; Staniloae CS; Mavromatis K
  • Circulating endothelial progenitor cell activity as a predictor of cardiovascular outcomes
    Volume: 51 Page(s): A305 - A305
    03/11/2008 Authors: Mavromatis K; Aznaouridis K; Ghasemzadeh N; Forghani Z; Veledar E; Sutcliffe D; Mihretu T; Kamineni T; Ishaque MR; Reddy PK
  • Association of endothelial progenitor cell colonies with cardiovascular risk factors
    Volume: 51 Page(s): A307 - A308
    03/11/2008 Authors: Aznaouridis K; Ozkor M; Murrow JR; Mavromatis K; Sher S; Jorgensen J; Sutcliffe DJ; Hameed S; Harris WAC; Taylor WR
  • Systemic inflammatory activation and endothelial repair after stenting: A comparison of drug-eluting stents with bare metal stents
    Volume: 100 Page(s): 172L - 172L
    10/20/2007 Authors: Mavromatis K; Aznaouridis K; Kamineni T; Hooper WC; Sutcliffe DJ; Ishaque MR; Pohlel FK; Taylor WR; Reddy PK; DeStaercke C
  • Association of endothelial precursor colony counts with cardiovascular risk burden
    Volume: 116 Page(s): 640 - 640
    10/16/2007 Authors: Al Mheid I; Ozkor M; Mavromatis K; Sher S; Aznaouddis K; Shirazi F; Kamineni TK; Ali M; Ali S; Sutcliffe D
  • Optimal medical therapy with or without PCI for stable coronary disease.
    N Engl J Med Volume: 356 Page(s): 1503 - 1516
    04/12/2007 Authors: Boden WE; O'Rourke RA; Teo KK; Hartigan PM; Maron DJ; Kostuk WJ; Knudtson M; Dada M; Casperson P; Harris CL
  • Pre-stent fractional flow reserve and stent diameter predict optimal post stent fractional flow reserve: Implications for selection of drug eluting stents
    Volume: 114 Page(s): 784 - 784
    10/31/2006 Authors: Samady H; McDaniel MC; Veledar E; De Bruyne B; Pijls NH; Helmy TA; Mavromatis K; Ghazzal ZM; Vaccarino V
  • Mobilization of endothelial progenitor cells with percutaneous coronary angioplasty: Effect of aging
    Volume: 112 Page(s): U195 - U195
    10/25/2005 Authors: Mavromatis K; Kamineni T; Veledar E; Ishaque MR; Pererira J; Douglas JS; Ghazzal Z; Liberman H; Rab T; Manoukian SV
  • Mobilization of endothelial progenitor cells with percutaneous coronary angioplasty in patients with and without acute coronary syndromes
    Volume: 96 Page(s): 72H - 72H
    10/17/2005 Authors: Mavromatis K; Veledar E; Kamineni T; Ishaque MR; Pererira J; Douglas JS; Ghazzal Z; Liberman H; Rab T; Manoukian SV
  • Impaired mobilization of circulating endothelial progenitor cells in patients with diabetes undergoing coronary stenting
    Volume: 45 Page(s): 387A - 387A
    02/01/2005 Authors: Mavromatis K; Ishaque MR; House D; Pereira J; Sutcliffe DJ; Danley J; Anderson G; Block PC; Weintraub WS; Taylor WR
  • Comparison of outcomes of percutaneous coronary intervention of ostial versus nonostial narrowing of the major epicardial coronary arteries.
    Am J Cardiol Volume: 94 Page(s): 583 - 587
    09/01/2004 Authors: Mavromatis K; Ghazzal Z; Veledar E; Diamandopoulos L; Weintraub WS; Douglas JS; Kalynych AM
  • Early effects of arterial hemodynamic conditions on human saphenous veins perfused ex vivo.
    Arterioscler Thromb Vasc Biol Volume: 20 Page(s): 1889 - 1895
    08/01/2000 Authors: Mavromatis K; Fukai T; Tate M; Chesler N; Ku DN; Galis ZS
  • Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt.
    Circulation Volume: 101 Page(s): 1722 - 1728
    04/11/2000 Authors: Somers MJ; Mavromatis K; Galis ZS; Harrison DG
  • Increased levels of superoxide induced by arterial hemodynamic conditions ex vivo may contribute to remodeling of human saphenous vein grafts
    CIRCULATION Volume: 100 Page(s): 411 - 411
    11/02/1999 Authors: Mavromatis K; Galis ZS
  • Mechanical stretching of human saphenous vein grafts induces expression and activation of matrix-degrading enzymes associated with vascular tissue injury and repair.
    Exp Mol Pathol Volume: 66 Page(s): 227 - 237
    08/01/1999 Authors: Meng X; Mavromatis K; Galis ZS
  • Effects of arterial hemodynamic conditions on early remodeling in ex vivo perfused human saphenous vein
    FASEB JOURNAL Volume: 13 Page(s): A44 - A44
    03/12/1999 Authors: Mavromatis K; Tate M; Chesler N; Ku D; Galis Z
  • The carboxyl-terminal zinc-binding domain of the human papillomavirus E7 protein can be functionally replaced by the homologous sequences of the E6 protein.
    Virus Res Volume: 52 Page(s): 109 - 118
    11/01/1997 Authors: Mavromatis KO; Jones DL; Mukherjee R; Yee C; Grace M; Mnger K
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements